Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham, Ananta Bangdiwala, Melanie R. Nicol, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 11, pp. e835-e843
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Cross Mark Policy

(2022)
Open Access | Times Cited: 1336
The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 423
A living WHO guideline on drugs to prevent covid-19
François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.
BMJ (2021), pp. n526-n526
Open Access | Times Cited: 118
Prophylaxis against covid-19: living systematic review and network meta-analysis
Jessica Bartoszko, Reed Siemieniuk, Elena Kum, et al.
BMJ (2021), pp. n949-n949
Open Access | Times Cited: 103
The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials
Kimberley Lewis, Dipayan Chaudhuri, Fayez Alshamsi, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0244778-e0244778
Open Access | Times Cited: 50
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 45
Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage
Nikhil Kirtipal, Sanjay Kumar, Sumit Kumar Dubey, et al.
Infection Genetics and Evolution (2022) Vol. 99, pp. 105254-105254
Open Access | Times Cited: 33
Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Xabier García‐Albéniz, Julia del Amo, Rosa Polo, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 8, pp. 789-796
Open Access | Times Cited: 28
Safety of Hydroxychloroquine for COVID-19 Prophylaxis in Healthcare Workers: A Cross-Sectional Study
H Kunj, Pramila Yadav, Mehak Dhande, et al.
Cureus (2025)
Open Access
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R. Nicol, Ananta Bangdiwala, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 11
Open Access | Times Cited: 48
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial
Ilan S. Schwartz, Mari E. Boesen, Graziela Cerchiaro, et al.
CMAJ Open (2021) Vol. 9, Iss. 2, pp. E693-E702
Open Access | Times Cited: 36
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)
Susanna Naggie, Aaron P. Milstone, Mario Castro, et al.
International Journal of Infectious Diseases (2023) Vol. 129, pp. 40-48
Open Access | Times Cited: 12
SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19
Daniel J. Clemens, Dan Ye, Wei Zhou, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282151-e0282151
Open Access | Times Cited: 12
Hydroxychloroquine in COVID-19 Patients: Pros and Cons
Nour K. Younis, Rana Zareef, Sally N. Al Hassan, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 33
The time to offer treatments for COVID-19
Binh Ngo, Paul E. Marik, Pierre Kory, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 5, pp. 505-518
Open Access | Times Cited: 31
Prophylaxis for COVID-19: a systematic review
Mikaëla Smit, Annalisa Marinosci, Thomas Agoritsas, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 4, pp. 532-537
Open Access | Times Cited: 27
Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
Jorge Rojas‐Serrano, Angélica Margarita Portillo-Vasquez, Ireri Thirión-Romero, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0261980-e0261980
Open Access | Times Cited: 20
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
William HK Schilling, Mavuto Mukaka, James J. Callery, et al.
PLoS Medicine (2024) Vol. 21, Iss. 9, pp. e1004428-e1004428
Open Access | Times Cited: 3
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
Ahmed S. Abdel‐Moneim, Elsayed M. Abdelwhab, Ziad A. Memish
Virology (2021) Vol. 558, pp. 1-12
Open Access | Times Cited: 24
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
Jogender Kumar, Siddharth Jain, Jitendra Meena, et al.
Journal of Infection and Chemotherapy (2021) Vol. 27, Iss. 6, pp. 882-889
Open Access | Times Cited: 24
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
Zelyn Lee, Craig R. Rayner, Jamie I. Forrest, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 35-38
Open Access | Times Cited: 26
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
Rosa Polo, Xabier García‐Albéniz, Carolina Terán, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 1, pp. 85-93
Open Access | Times Cited: 15
Care for adults with COVID ‐19: living guidelines from the National COVID ‐19 Clinical Evidence Taskforce
Heath White, Steve McDonald, Bridget E. Barber, et al.
The Medical Journal of Australia (2022) Vol. 217, Iss. 7, pp. 368-378
Open Access | Times Cited: 14
An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 8
Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer
Britney Niemann, Amanda Puleo, Conley Stout, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2551-2551
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top